Clinical trial
A Conversion Study to Assess Safety and Efficacy of a MR4 Based…
NCT00384202 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00384202 |
|---|---|
| Title | A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients |
| Official title | A Multicenter, Open, Single Sequence Crossover Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, FK506E (MR4), Based Immunosuppressive Regimen in Stable Liver Transplant Patients Converted From a Prograf® Based Immunosuppressive Regimen |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Transplantation |
| Intervention type | Drug |
| Interventions | Tacrolimus |
| Enrollment | 112 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Oct 5, 2006 |
| Last update posted | Jul 9, 2014 |
| Countries | France, Germany, Ireland, Poland, Spain, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: